AUSDRISK cut-off | ||||||
---|---|---|---|---|---|---|
Males | Females | |||||
≥12 | ≥16 | ≥20 | ≥12 | ≥16 | ≥20 | |
Age (years) | 62.0 | 62.8 | 65.5 | 61.7 | 62.4 | 65.0 |
Weight (kg) | 92.8 | 99.8 | 105.1 | 83.8 | 89.7 | 92.4 |
BMI (kg/m2) | 30.3 | 32.5 | 34.6 | 32.2 | 34.6 | 36.5 |
25 to <30 (%) | 42.5 | 29.4 | 17.0 | 30.6 | 21.4 | 21.7 |
≥30 (%) | 46.6 | 68.1 | 83.0 | 61.1 | 75.5 | 78.3 |
Waist circumference (cm) | 106.7 | 113.3 | 118.8 | 100.6 | 106.6 | 113.2 |
Male 94 to <102; female 80 to <88 (%) | 18.7 | 5.6 | 1.9 | 4.8 | 3.1 | 0.0 |
Male ≥102; female ≥88 (%) | 71.4 | 92.5 | 98.1 | 90.1 | 94.9 | 100.0 |
FPG (mmol/L) | 5.5 | 5.7 | 5.8 | 5.4 | 5.6 | 5.7 |
6.1–6.9 (%) | 11.2 | 13.4 | 20.8 | 4.4 | 3.5 | 10.5 |
≥7.0 (%) | 3.4 | 5.6 | 8.3 | 2.2 | 5.8 | 5.3 |
Total cholesterol (mmol/L) | 5.2 | 5.1 | 5.0 | 5.7 | 5.5 | 5.3 |
≥5.5 (%) | 42.2 | 36.9 | 30.2 | 56.4 | 48.0 | 34.8 |
HDL (mmol/L) | 1.3 | 1.2 | 1.2 | 1.5 | 1.4 | 1.4 |
Male <1.0; female <1.3 (%) | 15.7 | 20.0 | 20.8 | 22.6 | 27.6 | 34.8 |
LDL (mmol/L) | 3.2 | 3.0 | 2.9 | 3.4 | 3.2 | 3.1 |
≥3.5 (%) | 35.4 | 31.9 | 26.4 | 40.9 | 33.7 | 13.0 |
Triglycerides (mmol/L) | 1.8 | 1.9 | 2.0 | 1.8 | 1.9 | 1.9 |
≥2.0 (%) | 30.3 | 35.6 | 41.5 | 33.7 | 42.9 | 43.5 |
Systolic BP (mm Hg) | 141.6 | 145.2 | 149.3 | 139.1 | 141.1 | 141.2 |
≥140 (%) | 52.0 | 59.4 | 69.8 | 44.4 | 50.0 | 52.2 |
Diastolic BP (mm Hg) | 81.4 | 83.0 | 84.0 | 76.7 | 76.8 | 73.4 |
≥90 (%) | 23.1 | 26.9 | 28.3 | 11.9 | 12.2 | 4.4 |
MetS (%) | 57.3 | 71.1 | 83.3 | 59.6 | 70.1 | 89.5 |
AUSDRISK, Australian Type 2 Diabetes Risk Assessment Tool; BMI, body mass index; BP, blood pressure; FPG, fasting plasma glucose; GGT RFS, Greater Green Triangle Risk Factor Study; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MetS, metabolic syndrome.